These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31497674)

  • 1. Study protocol: Randomized controlled trial of web-based decision support tools for high-risk women and healthcare providers to increase breast cancer chemoprevention.
    Crew KD; Silverman TB; Vanegas A; Trivedi MS; Dimond J; Mata J; Sin M; Jones T; Terry MB; Tsai WY; Kukafka R
    Contemp Clin Trials Commun; 2019 Dec; 16():100433. PubMed ID: 31497674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Making Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trial.
    Crew KD; Anderson GL; Arnold KB; Stieb AP; Amenta JN; Collins N; Law CW; Pruthi S; Sandoval-Leon A; Bertoni D; Grosse Perdekamp MT; Colonna S; Krisher S; King T; Yee LD; Ballinger TJ; Braun-Inglis C; Mangino D; Wisinski KB; DeYoung CA; Ross M; Floyd J; Kaster A; Vander Walde L; Saphner T; Zarwan C; Lo S; Graham C; Conlin A; Yost K; Agnese D; Jernigan C; Hershman DL; Neuhouser ML; Arun B; Kukafka R
    Contemp Clin Trials; 2024 Jul; 142():107564. PubMed ID: 38704119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient and Provider Web-Based Decision Support for Breast Cancer Chemoprevention: A Randomized Controlled Trial.
    Crew KD; Bhatkhande G; Silverman T; Amenta J; Jones T; McGuinness JE; Mata J; Guzman A; He T; Dimond J; Tsai WY; Kukafka R
    Cancer Prev Res (Phila); 2022 Oct; 15(10):689-700. PubMed ID: 35679576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceptions of Racially and Ethnically Diverse Women at High Risk of Breast Cancer Regarding the Use of a Web-Based Decision Aid for Chemoprevention: Qualitative Study Nested Within a Randomized Controlled Trial.
    Jones T; Guzman A; Silverman T; Freeman K; Kukafka R; Crew K
    J Med Internet Res; 2021 Jun; 23(6):e23839. PubMed ID: 34100769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot study of decision support tools on breast cancer chemoprevention for high-risk women and healthcare providers in the primary care setting.
    Kukafka R; Fang J; Vanegas A; Silverman T; Crew KD
    BMC Med Inform Decis Mak; 2018 Dec; 18(1):134. PubMed ID: 30558581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative analysis of shared decision-making for chemoprevention in the primary care setting: provider-related barriers.
    Jones T; Silverman T; Guzman A; McGuinness JE; Trivedi MS; Kukafka R; Crew KD
    BMC Med Inform Decis Mak; 2022 Aug; 22(1):208. PubMed ID: 35927732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of web-based decision support to improve informed choice for chemoprevention: a qualitative analysis of pre-implementation interviews (SWOG S1904).
    Michel AM; Yi H; Amenta J; Collins N; Vaynrub A; Umakanth S; Anderson G; Arnold K; Law C; Pruthi S; Sandoval-Leon A; Shirley R; Perdekamp MG; Colonna S; Krisher S; King T; Yee LD; Ballinger TJ; Braun-Inglis C; Mangino DA; Wisinski K; DeYoung CA; Ross M; Floyd J; Kaster A; VanderWalde L; Saphner TJ; Zarwan C; Lo S; Graham C; Conlin A; Yost K; Agnese D; Jernigan C; Hershman DL; Neuhouser ML; Arun B; Crew KD; Kukafka R
    BMC Med Inform Decis Mak; 2024 Sep; 24(1):272. PubMed ID: 39334347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A web-based personalized risk communication and decision-making tool for women with dense breasts: Design and methods of a randomized controlled trial within an integrated health care system.
    Knerr S; Wernli KJ; Leppig K; Ehrlich K; Graham AL; Farrell D; Evans C; Luta G; Schwartz MD; O'Neill SC
    Contemp Clin Trials; 2017 May; 56():25-33. PubMed ID: 28257920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addressing barriers to uptake of breast cancer chemoprevention for patients and providers.
    Crew KD
    Am Soc Clin Oncol Educ Book; 2015; ():e50-8. PubMed ID: 25993215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Informed choice about breast cancer prevention: randomized controlled trial of an online decision aid intervention.
    Korfage IJ; Fuhrel-Forbis A; Ubel PA; Zikmund-Fisher BJ; Greene SM; McClure JB; Smith DM; Alford SH; Fagerlin A
    Breast Cancer Res; 2013; 15(5):R74. PubMed ID: 24004815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1/2 genetic counseling referral in primary care.
    Silverman TB; Vanegas A; Marte A; Mata J; Sin M; Ramirez JCR; Tsai WY; Crew KD; Kukafka R
    BMC Health Serv Res; 2018 Aug; 18(1):633. PubMed ID: 30103738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast Cancer Chemoprevention: A Practical Guide for the Primary Care Provider.
    Farkas A; Vanderberg R; Merriam S; DiNardo D
    J Womens Health (Larchmt); 2020 Jan; 29(1):46-56. PubMed ID: 31560601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen vs Raloxifene vs Exemestane for Chemoprevention.
    Reimers L; Crew KD
    Curr Breast Cancer Rep; 2012 Sep; 4(3):207-215. PubMed ID: 23956815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies to Identify and Recruit Women at High Risk for Breast Cancer to a Randomized Controlled Trial of Web-based Decision Support Tools.
    McGuinness JE; Bhatkhande G; Amenta J; Silverman T; Mata J; Guzman A; He T; Dimond J; Jones T; Kukafka R; Crew KD
    Cancer Prev Res (Phila); 2022 Jun; 15(6):399-406. PubMed ID: 35412592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What Factors Influence Decision-Making about Breast Cancer Chemoprevention among High-Risk Women?
    Crew KD
    Cancer Prev Res (Phila); 2017 Nov; 10(11):609-611. PubMed ID: 28978567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ.
    Reimers LL; Sivasubramanian PS; Hershman D; Terry MB; Greenlee H; Campbell J; Kalinsky K; Maurer M; Jayasena R; Sandoval R; Alvarez M; Crew KD
    Breast J; 2015; 21(4):377-86. PubMed ID: 25879521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine prevention of breast cancer.
    Jahan N; Jones C; Rahman RL
    Mol Cell Endocrinol; 2021 Jun; 530():111284. PubMed ID: 33882282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care: A Cluster Randomized Clinical Trial.
    Kukafka R; Pan S; Silverman T; Zhang T; Chung WK; Terry MB; Fleck E; Younge RG; Trivedi MS; McGuinness JE; He T; Dimond J; Crew KD
    JAMA Netw Open; 2022 Jul; 5(7):e2222092. PubMed ID: 35849397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprevention Uptake among Women with Atypical Hyperplasia and Lobular and Ductal Carcinoma
    Trivedi MS; Coe AM; Vanegas A; Kukafka R; Crew KD
    Cancer Prev Res (Phila); 2017 Aug; 10(8):434-441. PubMed ID: 28611039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.